肥胖症与甲状旁腺激素相关性的研究现状及进展
Research Status and Progress on the Correlation between Obesity and Parathyroid Hormone
DOI: 10.12677/acm.2025.15102842, PDF,   
作者: 邓佳星:重庆医科大学,重庆;重庆市合川太和中心卫生院外科,重庆;周志益*:重庆医科大学,重庆;重庆市人民医院全科医学科,重庆
关键词: 肥胖症甲状旁腺激素代谢异常相关性Obesity Parathyroid Hormone Metabolic Abnormalities Relevance
摘要: 肥胖症与甲状旁腺激素(PTH)之间存在复杂关联。肥胖症是一种由多种因素引发的慢性代谢性疾病,其发病率不断攀升,对健康影响广泛。PTH在钙磷代谢等方面发挥关键作用。研究二者相关性,有助于深入理解肥胖症的发病机制及相关并发症,为肥胖症的防治提供新方向。本文从肥胖症和PTH的基本概念出发,详细阐述了肥胖症患者PTH水平的变化情况,分析了PTH与肥胖症相关代谢异常(如脂质、葡萄糖和胰岛素代谢)的关系,探讨了影响肥胖症患者PTH水平的因素,总结了当前研究的成果与不足,并对未来研究方向进行了展望。
Abstract: There is a complex association between obesity and parathyroid hormone (PTH). Obesity is a chronic metabolic disease caused by multiple factors. Its incidence rate is constantly rising and it has a wide range of impacts on health. PTH plays a key role in calcium and phosphorus metabolism and other aspects. Studying the correlation between the two is conducive to a deeper understanding of the pathogenesis and related complications of obesity, and provides a new direction for the prevention and treatment of obesity. Starting from the basic concepts of obesity and PTH, this article elaborates in detail on the changes in PTH levels in obese patients, analyzes the relationship between PTH and obesity-related metabolic abnormalities (such as lipid, glucose and insulin metabolism), explores the factors influencing PTH levels in obese patients, and summarizes the achievements and deficiencies of current research. And the future research directions were prospected.
文章引用:邓佳星, 周志益. 肥胖症与甲状旁腺激素相关性的研究现状及进展[J]. 临床医学进展, 2025, 15(10): 953-961. https://doi.org/10.12677/acm.2025.15102842

参考文献

[1] Wang, L., Zhou, B., Zhao, Z., Yang, L., Zhang, M., Jiang, Y., et al. (2021) Body-Mass Index and Obesity in Urban and Rural China: Findings from Consecutive Nationally Representative Surveys during 2004-18. The Lancet, 398, 53-63. [Google Scholar] [CrossRef] [PubMed]
[2] 中国医疗保健国际交流促进会营养与代谢管理分会, 中国营养学会临床营养分会, 中华医学会糖尿病学分会, 等. 中国超重/肥胖医学营养治疗指南(2021) [J]. 中国医学前沿杂志(电子版), 2021, 13(11): 1-55.
[3] Avgerinos, K.I., Spyrou, N., Mantzoros, C.S. and Dalamaga, M. (2019) Obesity and Cancer Risk: Emerging Biological Mechanisms and Perspectives. Metabolism, 92, 121-135. [Google Scholar] [CrossRef] [PubMed]
[4] Goltzman, D. (2018) Physiology of Parathyroid Hormone. Endocrinology and Metabolism Clinics of North America, 47, 743-758. [Google Scholar] [CrossRef] [PubMed]
[5] 吴苏宁, 董维福, 马秀财. 肥胖对改良小切口甲状腺癌全切术后甲状旁腺功能及生活质量的影响[J]. 中国肿瘤临床与康复, 2021, 28(11): 1349-1353.
[6] 魏洪亮, 李信, 温鑫鑫, 李一可, 徐昕. 肥胖对甲状腺癌全切术后甲状旁腺功能的影响[J]. 现代肿瘤医学, 2021, 29(16): 2802-2805.
[7] 刘俊松, 姚小宝, 许崇文, 赵谦, 赵瑞敏, 李宏慧, 张少强. BMI对甲状腺全切术后甲状旁腺功能恢复的影响[J]. 现代肿瘤医学, 2020, 28(15): 2593-2597.
[8] 樊则琴. 阻塞性睡眠呼吸暂停低通气综合征中维生素D、甲状旁腺激素与胰岛素抵抗的相关性分析[D]: [硕士学位论文]. 广州: 南方医科大学, 2020.
[9] 秦曹李弢. 过表达甲状旁腺激素相关蛋白抑制高脂饮食小鼠胰岛胞凋亡的机制研究[D]: [博士学位论文]. 广州: 南方医科大学, 2019.
[10] 郑蓉蓉, 胡玲. 血清维生素D、甲状旁腺激素调节糖代谢的研究进展[J]. 世界最新医学信息文摘, 2018, 18(34): 86-87.